Answer
Jentadueto (linagliptin + metformin) has no or negligible influence on driving or using machines, but patients should be alerted to hypoglycaemia risk when it is combined with other diabetes medicines known to cause hypoglycaemia, such as sulphonylureas.
Sources for this answer
- Jentadueto 2.5 mg/850 mg and 2.5 mg/1,000 mg film-coated tabletsBoehringer Ingelheim Limited · emc · SmPC §4.7 Effects on ability to drive and use machines · Version 24Document updated
Sources checked